Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Yibirin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cureus|January 30, 2024
The Impact of Artificial Sweeteners on Human Health and Cancer Association: A Comprehensive Clinical ReviewWissam Ghusn, Roopa Naik, Marcel Yibirin
Cureus|April 21, 2021
A Case of Dysembryoplastic Neuroepithelial Tumor in an Adolescent MaleMarcel Yibirin, Diana De Oliveira, Isabella Suarez, et al.
Cureus|February 22, 2021
Adverse Effects Associated with Proton Pump Inhibitor UseMarcel Yibirin, Diana De Oliveira, Roberto Valera, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 2022
Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational studyGeorgios Angelidakis, Haley Pritchard, Marcel Yibirin, et al.
European Journal of Gastroenterology & Hepatology|September 5, 2022
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virusMarcel Yibirin, Jeff Hosry, Eduardo Yepez Guevara, et al.
Cancers|May 14, 2022
Overcoming Therapy Resistance in Colon Cancer by Drug RepurposingTalal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, et al.
Medicine|September 20, 2022
Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignanciesHarrys A Torres, Georgios Angelidakis, Ying Jiang, et al.
The American Journal of Gastroenterology|June 12, 2023
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid TumorsMarcel Yibirin, Khalis Mustafayev, Jeff Hosry, et al.
Medrxiv : the Preprint Server for Health Sciences|September 13, 2022
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on SurvivorshipIssam Raad, Ray Hachem, Nigo Masayuki, et al.
Elife|January 30, 2023
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorshipIssam I Raad, Ray Hachem, Nigo Masayuki, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cureus|January 30, 2024
The Impact of Artificial Sweeteners on Human Health and Cancer Association: A Comprehensive Clinical ReviewWissam Ghusn, Roopa Naik, Marcel Yibirin
Cureus|April 21, 2021
A Case of Dysembryoplastic Neuroepithelial Tumor in an Adolescent MaleMarcel Yibirin, Diana De Oliveira, Isabella Suarez, et al.
Cureus|February 22, 2021
Adverse Effects Associated with Proton Pump Inhibitor UseMarcel Yibirin, Diana De Oliveira, Roberto Valera, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 2022
Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational studyGeorgios Angelidakis, Haley Pritchard, Marcel Yibirin, et al.
European Journal of Gastroenterology & Hepatology|September 5, 2022
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virusMarcel Yibirin, Jeff Hosry, Eduardo Yepez Guevara, et al.
Cancers|May 14, 2022
Overcoming Therapy Resistance in Colon Cancer by Drug RepurposingTalal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, et al.
Medicine|September 20, 2022
Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignanciesHarrys A Torres, Georgios Angelidakis, Ying Jiang, et al.
The American Journal of Gastroenterology|June 12, 2023
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid TumorsMarcel Yibirin, Khalis Mustafayev, Jeff Hosry, et al.
Medrxiv : the Preprint Server for Health Sciences|September 13, 2022
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on SurvivorshipIssam Raad, Ray Hachem, Nigo Masayuki, et al.
Elife|January 30, 2023
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorshipIssam I Raad, Ray Hachem, Nigo Masayuki, et al.
Pageof 1